Jun 2026 (Q2 FY26) — Aug 6, 2026
CareCloud Q2 FY26 — Strong Recurring Revenue Growth and Capital Structure Simplification
Read the full callCareCloud (CCLD) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
CareCloud earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 31.9 | +16.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 5.8 | −5.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 1.1 | −61.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$1.8 −2.70% · −$0.05
Performance −41.9% 1Y
1Y: $3.1 on 17 Oct 2025 → $1.8. High $3.81 (26 Mar 2026), low $1.77 (14 Oct 2026).
- Previous close
- $1.85
- 52-week range
- $1.77 – $3.81
- One year
- −45.62%
Overview
- Symbol
- CCLD
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
CareCloud earnings calls (CCLD)
Financials
What the filings say
Net profit, year on year: −61% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 29 | 28 | 28 | 27 | 31 | 34 | 31 | 32 |
| Operating profit | 3 | 3 | 2 | 3 | 3 | 3 | 1 | 2 |
| Operating margin | 11.4% | 12.2% | 7.3% | 10.9% | 10.3% | 9.1% | 3.2% | 5.8% |
| Profit before tax | 3 | 3 | 2 | 3 | 3 | 3 | 1 | 1 |
| Tax rate | 1.3% | 1.2% | 2.1% | 1.4% | 1.4% | 2.5% | 5.3% | 8.3% |
| Net profit | 3 | 3 | 2 | 3 | 3 | 3 | 1 | 1 |
| EPS ($ per share) | 0.04 | — | 0.04 | 0.04 | 0.04 | — | 0.01 | 0 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -24 | -25 | -34 | -31 | -26 | -74 | -67 | -56 |
| Total liabilities | 9 | 14 | 37 | 43 | 34 | 36 | 22 | 28 |
| Fixed assets | 2 | 3 | 5 | 5 | 5 | 5 | 5 | 8 |
| Total assets | 48 | 56 | 138 | 141 | 136 | 78 | 72 | 88 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 7 | 8 | -1 | 13 | 21 | 15 | 21 | 29 |
| Cash from investing | -14 | -4 | -31 | -23 | -12 | -12 | -7 | -25 |
| Cash from financing | 18 | 1 | 33 | -1 | -8 | -13 | -11 | -6 |
| Net cash flow | 10 | 6 | 1 | -11 | 2 | -9 | 2 | -2 |
| Capital expenditure | -1 | -2 | -3 | -3 | -3 | -3 | -2 | -5 |
| Free cash flow | 6 | 6 | -3 | 10 | 19 | 12 | 19 | 24 |
Insider filings
22 filings between Nov 10, 2025 and Aug 8, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$51.1K
1 sale by 1 insider
Compensation
not trading decisions- 17
- Option exercise — converted options into shares
Also filed: 4 dispositions to the issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| DALY JOHN N | — | $51.1K | Nov 10, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 8, 2026 | MUNTER CAMERON Director | Option exercise | 7,500 | $0 |
| Aug 8, 2026 | Sharnak Lawrence Steven Director | Option exercise | 7,500 | $0 |
| Aug 8, 2026 | KORN BILL Director | Option exercise | 7,500 | $0 |
| Aug 8, 2026 | BUSQUET ANNE Director | Option exercise | 7,500 | $0 |
| Jul 31, 2026 | Sharnak Lawrence Steven Director | Option exercise | 6,250 | $0 |
| Jul 31, 2026 | KORN BILL Director | Option exercise | 6,250 | $0 |
| Jul 31, 2026 | MUNTER CAMERON Director | Option exercise | 6,250 | $0 |
| Jul 31, 2026 | BUSQUET ANNE Director | Option exercise | 6,250 | $0 |
| May 15, 2026 | SNYDER STEPHEN ANDREW Chief Executive Officer | Disposition to issuer | 30,790 | $777.4K |
| May 15, 2026 | Chaudhry A Hadi Chief Strategy Officer | Disposition to issuer | 7,800 | $196.9K |
| May 15, 2026 | KORN BILL Director | Disposition to issuer | 10,800 | $272.7K |
| May 15, 2026 | ROTH NORMAN Interim CFO and Controller | Disposition to issuer | 6,500 | $164.1K |
| Feb 8, 2026 | KORN BILL Director | Option exercise | 7,500 | $0 |
| Feb 8, 2026 | BUSQUET ANNE Director | Option exercise | 7,500 | $0 |
| Feb 8, 2026 | MUNTER CAMERON Director | Option exercise | 7,500 | $0 |
| Feb 8, 2026 | Sharnak Lawrence Steven Director | Option exercise | 7,500 | $0 |
| Jan 31, 2026 | MUNTER CAMERON Director | Option exercise | 6,250 | $0 |
| Jan 31, 2026 | BUSQUET ANNE Director | Option exercise | 6,250 | $0 |
| Jan 31, 2026 | Sharnak Lawrence Steven Director | Option exercise | 6,250 | $0 |
| Jan 31, 2026 | KORN BILL Director | Option exercise | 6,250 | $0 |
| Dec 2, 2025 | DALY JOHN N Director | Option exercise | 40,000 | $0 |
| Nov 10, 2025 | DALY JOHN N Director | Sale | 15,000 | $51.1K |
| Sep 29, 2025 | HAQ MAHMUD UL Executive Chairman | Sale | 11,960 | $252.1K |
| Aug 8, 2025 | BUSQUET ANNE Director | Option exercise | 7,500 | $0 |
| Aug 8, 2025 | MUNTER CAMERON Director | Option exercise | 7,500 | $0 |
| Aug 8, 2025 | Sharnak Lawrence Steven Director | Option exercise | 7,500 | $0 |
| Aug 8, 2025 | KORN BILL Director | Option exercise | 7,500 | $0 |
| Aug 8, 2025 | DALY JOHN N Director | Option exercise | 7,500 | $0 |
| Aug 1, 2025 | BUSQUET ANNE Director | Option exercise | 7,500 | $0 |
| Aug 1, 2025 | KORN BILL Director | Option exercise | 7,500 | $0 |
| Aug 1, 2025 | Sharnak Lawrence Steven Director | Option exercise | 7,500 | $0 |
| Aug 1, 2025 | DALY JOHN N Director | Option exercise | 7,500 | $0 |
| Aug 1, 2025 | MUNTER CAMERON Director | Option exercise | 7,500 | $0 |
| Jun 17, 2025 | DALY JOHN N Director | Sale | 15,000 | $31.6K |
| Feb 8, 2025 | Sharnak Lawrence Steven Director | Option exercise | 7,500 | $0 |
| Feb 8, 2025 | KORN BILL Director | Option exercise | 7,500 | $0 |
| Feb 8, 2025 | BUSQUET ANNE Director | Option exercise | 7,500 | $0 |
| Feb 8, 2025 | MUNTER CAMERON Director | Option exercise | 7,500 | $0 |
| Feb 8, 2025 | DALY JOHN N Director | Option exercise | 7,500 | $0 |
| Feb 1, 2025 | MUNTER CAMERON Director | Option exercise | 7,500 | $0 |
| Feb 1, 2025 | KORN BILL Director | Option exercise | 7,500 | $0 |
| Feb 1, 2025 | DALY JOHN N Director | Option exercise | 7,500 | $0 |
| Feb 1, 2025 | BUSQUET ANNE Director | Option exercise | 7,500 | $0 |
| Feb 1, 2025 | Sharnak Lawrence Steven Director | Option exercise | 7,500 | $0 |
| Dec 31, 2024 | DALY JOHN N Director | Sale | 5,000 | $19.4K |
| Dec 16, 2024 | HAQ MAHMUD UL Executive Chairman | Option exercise | 12,000 | $0 |
| Dec 16, 2024 | HAQ MAHMUD UL Executive Chairman | Tax withheld | 5,520 | $101.0K |
| Dec 16, 2024 | ROTH NORMAN Interim CFO and Controller | Option exercise | 10,000 | $0 |
| Dec 16, 2024 | ROTH NORMAN Interim CFO and Controller | Tax withheld | 3,500 | $64.0K |
| Dec 16, 2024 | SNYDER STEPHEN ANDREW President | Option exercise | 12,000 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for CareCloud, Inc.
Free account. Everything above stays public.
Write why you follow CareCloud, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading